By Benjamin Horney ( November 13, 2019, 5:12 PM EST) -- Merck & Co., with help from Covington & Burling, has agreed to buy venture capital-backed Calporta Therapeutics Inc., which is developing potential treatments for neurodegenerative disorders including Alzheimer's and Parkinson's diseases, for up to $576 million, the companies said Wednesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.